Skip to content
Disclosery

Syncona Portfolio Ltd

Follow

13F filer, CIK 1725042, St Peter Port, Guernsey, United Kingdom

Syncona Portfolio Ltd reported $26,625,152 across 1 holding for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-07.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-338587

Period
2026-06-30
Reported value
$26.6M
Holdings
1
Top 10 weight
100%
New
0
Sold out
1

Part of the filer group Syncona Portfolio Ltd

How groups are built

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IPSCexited-1,213,056-$2.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001193125-26-338587, largest first. % of portfolio is the value over $26,625,152, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 18,554,624 shares; 2024Q4: 16,640,720 shares; 2025Q1: 16,640,720 shares; 2025Q2: 16,640,720 shares; 2025Q3: 16,640,720 shares; 2025Q4: 16,640,720 shares; 2026Q1: 16,640,720 shares; 2026Q2: 16,640,720 shares 16,640,720$26.6M100%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IPSCCENTURY THERAPEUTICS INC1,213,056$2.74Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-338587 base2026-08-07acceptance time not in the bulk data set